While sifting through the bacterial genome of salmonella, Cornell food scientists discovered mcr-9, a new, stealthy jumping gene so diabolical and robust that it resists one of the world's few last-resort antibiotics.
May 7, 2019
0
385
Emory microbiologists have detected "heteroresistance" to colistin, a last-resort antibiotic, in already highly resistant Klebsiella pneumoniae, a bacterium that causes blood, soft tissue and urinary tract infections.
Mar 6, 2018
0
434
McMaster University researchers have discovered a combination punch to treat drug-resistant infections that is showing promise based on testing in mice.
May 14, 2020
0
26
A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents of rural communities in Vietnam to find that the prevalence of colistin-resistant Escherichia coli (CR-E) ...
Dec 20, 2018
0
2
New research due to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) has identified the dangerous mcr-1 gene -which provides resistance to the last line antibiotic colistin—in ...
Apr 20, 2020
0
2
(Medical Xpress) -- An ongoing study led by a University of Pittsburgh researcher has established the first scientifically-based dosing guidelines for a more than 50-year-old drug that has re-emerged as the best, and often ...
Jul 4, 2011
0
0
Bacteria—especially Gram-negative strains—are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed. Faced with these challenges, investigators are studying ...
Aug 10, 2018
0
3
Researchers from the University of Oxford, U.K., have investigated the evolution of antibiotic resistance properties of antimicrobial peptides (AMPs). In the paper "The evolution of colistin resistance increases bacterial ...
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microbiology. ...
May 21, 2013
0
0
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
May 16, 2023
0
50
